ST ELIZABETH BOARDMAN HEALTH CTR — History
CCN 360276 | 3-year financial timeline | COVID resilience: 64/100
🛡️ Public data only — no PHI permitted on this instance.
$267M
Latest Revenue (FY2022)
+11.0%
Revenue CAGR (3yr)
10.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $217M | $271M | $267M | -1.4% | +11.0% |
| Operating Expenses | $192M | $222M | $238M | +7.3% | +11.3% |
| Operating Margin | 11.3% | 18.1% | 10.9% | -39.8% | -1.7% |
| Net Income | $24M | $49M | $29M | -40.7% | +9.2% |
| Licensed Beds | 206 | 206 | 206 | +0.0% | +0.0% |
| Total Patient Days | 54,583 | 64,137 | 64,525 | +0.6% | +8.7% |
| Medicare Day % | 22% | 19% | 20% | +2.2% | -4.6% |
| Medicaid Day % | 2% | 2% | 3% | +42.9% | +19.3% |
COVID Impact & Recovery
Resilience Score: 64/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +23.3% ($217M → $267M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+11.0%
This Hospital
+7.6%
State Avg
Latest Margin
10.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $292M | 10.7% |
| FY2024 (proj) | $318M | 10.5% |
| FY2025 (proj) | $343M | 10.3% |